TickerFactsScreenerDevelopers

GYRE THERAPEUTICS, INC. (GYRE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $200.0K2010: $3.31M2011: $1.43M2012: $333.0K2013: $41.0K2014: $4.0K2015: $272.0K2016: $468.0K2017: $23.0K2018: $376.0K2019: $64.0K2021: $839.0K2022: $4.99M2023: $8.52M2024: $2.31M2025: $1.19M$1.19M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.19M-48.6%
2024$2.31M-72.8%
2023$8.52M+70.9%
2022$4.99M+494.2%
2021$839.0K—
2019$64.0K-83.0%
2018$376.0K+1534.8%
2017$23.0K-95.1%
2016$468.0K+72.1%
2015$272.0K+6700.0%
2014$4.0K-90.2%
2013$41.0K-87.7%
2012$333.0K-76.7%
2011$1.43M-56.8%
2010$3.31M+1555.5%
2009$200.0K—